Question:
Identify phase of clinical trial having following features:
(A) Trial is conducted on about 3000 patients
(B) Purpose of trial is therapeutic confirmation
(C) Safety and tolerability is evaluated on wider scale
(D) Completion of trial is followed by New Drug Application (NDA)
Identify phase of clinical trial having following features:
(A) Trial is conducted on about 3000 patients
(B) Purpose of trial is therapeutic confirmation
(C) Safety and tolerability is evaluated on wider scale
(D) Completion of trial is followed by New Drug Application (NDA)
(A) Trial is conducted on about 3000 patients
(B) Purpose of trial is therapeutic confirmation
(C) Safety and tolerability is evaluated on wider scale
(D) Completion of trial is followed by New Drug Application (NDA)
Updated On: Jul 23, 2024
- Phase - I
- Phase - II
- Phase - III
- Phase - IV
Hide Solution
Verified By Collegedunia
The Correct Option is C
Solution and Explanation
The correct option is (C): Phase - III
Was this answer helpful?
0
0
Top Questions on Clinical Trial Fundamentals
- When a New Drug Application (NDA) made?
- GPAT - 2023
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
- Match List I with List II
List I List II A Phase‐I I Post marketing surveillance B Phase‐0 II Micro dosing C Phase‐3 III First in human dose D Phase‐4 IV Multicentric trials
Choose the correct answer from the options given below:- GPAT - 2022
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
- To monitor the safety of the new drug under actual conditions of use in large number of patients has been classified as____ clinical trials.
- GPAT - 2021
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
- The number of subjects required in a phase 1 clinical trial is:-
- GPAT - 2018
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
- Efficiency of drug is checked in modest population in
- GPAT - 2015
- GPAT - 2016
- Clinical Pharmacy and Therapeutics
- Clinical Trial Fundamentals
View More Questions
Questions Asked in GPAT exam
- Match the following:
(P) Schedule H
(Q) Schedule G
(R) Schedule P
(S) Schedule F2
Descriptions:
(I) Life period of drugs
(II) Drugs used under RMP
(III) List of Prescription Drugs
(IV) Standards for surgical dressing- GPAT - 2025
- Drug therapy
- Minimum manufacturing space for 'Habb-Unani medicine' as per Schedule of D and C Act?
- GPAT - 2025
- Pharma Techniques
- If the label or the container bears the name of an individual or company purporting to be the manufacturer of the drug, which individual or company is fictitious or does not exist, it is:
- GPAT - 2025
- Drug therapy
- Match the following:
(1) Schedule FF
(2) Schedule F3
(3) Schedule V
(4) Schedule Y
Descriptions:
(P) Standards of patent and proprietary medicines
(Q) Requirements and guidelines for clinical trials
(R) Standards for sterilized umbilical tapes
(S) Standards for Ophthalmic preparations- GPAT - 2025
- Drug therapy
Match the following Class and their Drug:
(1) Alkylating (P) 5-fluorouracil
(2) Platinum analog (Q) Cisplatin
(3) Antimetabolite (R) Cetuximab
(4) EGF receptor inhibitor (S) Chlorambucil- GPAT - 2025
- Biostatistics and Research Methodology
View More Questions